23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo]
RxNorm concept 2693465, branded drug (sbd). Prescribable name: Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML Injection.
- RxCUI
- 2693465
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693465 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ocrevus Zunovo (ocrelizumab-hyaluronidase-ocsq 920 MG / 23,000 UNT) per 23 ML Injection
Related concepts
- ocrelizumab-ocsq 40 MG/ML (SCDC, consists of)
- hyaluronidase-ocsq 1000 UNT/ML (SCDC, consists of)
- hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML [Ocrevus Zunovo] (SBDC, consists of)
- Injection (DF, has dose form)
- Ocrevus Zunovo (BN, has ingredient)
- 23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2693465 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693465 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693465. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.